A human BRCA2-knockout colorectal cancer model used to study homologous recombination deficiency, DNA damage repair, and PARP inhibitor sensitivity. Exclusive to CancerTools. Save 30% on this cell line this summer. Use code SUM26CELL at checkout.
![HCT 116 BRCA2 -/- [42] Cell Line. Early log phase. Image courtesy of the European Collection of Authenticated Cell Cultures (ECACC), UK.](https://cancertools.org/wp-content/uploads/HCT-116-BRCA2-42-Cell-Line.-Early-log-phase.png)
![HCT 116 BRCA2 -/- [42] Cell Line. Late log phase. Image courtesy of the European Collection of Authenticated Cell Cultures (ECACC), UK.](https://cancertools.org/wp-content/uploads/HCT-116-BRCA2-42-Cell-Line.-Late-log-phase.png)
Please note we may take up to three days to respond to your enquiry.
CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.
![HCT 116 BRCA2 -/- [42] Cell Line. Early log phase. Image courtesy of the European Collection of Authenticated Cell Cultures (ECACC), UK.](https://cancertools.org/wp-content/uploads/HCT-116-BRCA2-42-Cell-Line.-Early-log-phase-300x222.png)
![HCT 116 BRCA2 -/- [42] Cell Line. Late log phase. Image courtesy of the European Collection of Authenticated Cell Cultures (ECACC), UK.](https://cancertools.org/wp-content/uploads/HCT-116-BRCA2-42-Cell-Line.-Late-log-phase-300x221.png)
Powered by Bioz 
